美国食品和药物管理局 (FDA) 批准摘要:根据项目更新,更新capecitabine标签
Sundeep Agrawal1,2, Clara Lee2, William F Pierce2
1Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.
概括
美国食品和药物管理局 (FDA) 通过Project Renewal更新了capecitabine的处方信息,包括新的指示和安全细节,以确保当前的临床相关瘤药物指导.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 监管科学 监管科学
背景情况:
- 皮他是一种口服化疗剂,用于各种癌症治疗.
- 现有的处方信息需要定期更新,以反映当前的科学知识和临床实践.
- 美国处方信息 (USPI) 对较旧的瘤药物可能并不总是最新的.
研究的目的:
- 总结一下FDA对修订capecitabine的USPI的方法.
- 详细说明了对capecitabine的指示,剂量和安全性信息的更新.
- 为了在FDA的项目更新计划中将这些修订置于背景下.
主要方法:
- 审查和批准对capecitabine的补充新药申请 (NDAs).
- 对现有指示和剂量方案的拟议修订的评估.
- 评估最新的安全信息,包括与二皮里米丁脱酶 (DPD) 缺乏相关的风险.
主要成果:
- 美国食品和药物管理局于2022年12月14日批准了对capecitabine的修订USPI.
- 更新包括修订和新的适应症,更新的剂量方案和增强的安全信息.
- 特别注意的是,在患有DPD缺乏症的患者中,对capecitabine的风险给予了特别注意.
结论:
- 这些修订确保了capecitabine处方信息在临床上具有意义,并且在科学上是最新的.
- 项目更新促进了对较旧的瘤药物处方信息的现代化.
- 更新的USPI支持在癌症治疗中安全有效地使用capecitabine.
更多相关视频
09:53Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
Published on: November 30, 2016
12.1K
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K